L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles

Area of Science:

• Nanotechnology
• Neuroscience
• Biomedical Engineering

Background:

• The blood-brain barrier (BBB) restricts the delivery of therapeutics to the brain, hindering treatment for neurological diseases.
• The large neutral amino acid transporter 1 (LAT1) facilitates the brain uptake of L-DOPA, a crucial drug for Parkinson's disease.
• Developing efficient brain-penetrating nanocarriers is essential for targeted drug delivery across the BBB.

Purpose of the Study:

• To synthesize and evaluate L-DOPA-functionalized gold nanoparticles (L-DOPA-AuNFs) as novel nanovehicles for crossing the BBB.
• To assess the BBB penetration efficiency of L-DOPA-AuNFs compared to non-targeted nanoparticles.
• To investigate the interaction of L-DOPA-AuNFs with brain macrophages and their inflammatory potential.

Main Methods:

• Synthesis of multi-branched nanoflower-like gold nanoparticles (AuNFs) using catechols as reducing and capping agents.
• Functionalization of AuNFs with L-DOPA to target the LAT1 transporter.
• In vitro and in vivo evaluation of BBB penetration and cellular uptake in brain macrophages.

Main Results:

• L-DOPA-AuNFs demonstrated significantly enhanced BBB penetration compared to control nanoparticles of similar size and shape.
• The synthesized nanoparticles were efficiently internalized by brain macrophages.
• L-DOPA-AuNFs did not induce an inflammatory response in brain macrophages.

Conclusions:

• L-DOPA-AuNFs serve as effective, non-inflammatory nanovehicles for targeted drug delivery across the BBB.
• This nanotechnology offers a promising strategy for overcoming the challenge of brain drug delivery.
• The L-DOPA targeting mechanism holds potential for treating various brain diseases.